Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 in French Nursing Homes during the Second Pandemic Wave: A Mixed-Methods Cross-Sectional Study

View ORCID ProfileMorgane Dujmovic, View ORCID ProfileThomas Roederer, View ORCID ProfileSéverine Frison, Carla Melki, Thomas Lauvin, View ORCID ProfileEmmanuel Grellety
doi: https://doi.org/10.1101/2021.12.12.21267681
Morgane Dujmovic
1Epicentre, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Morgane Dujmovic
Thomas Roederer
1Epicentre, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Roederer
  • For correspondence: thomas.roederer@epicentre.msf.org
Séverine Frison
1Epicentre, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Séverine Frison
Carla Melki
2Médecins Sans Frontières, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Lauvin
2Médecins Sans Frontières, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: thomas.roederer@epicentre.msf.org
Emmanuel Grellety
1Epicentre, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emmanuel Grellety
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Introduction French nursing homes were deeply affected by the first wave of the COVID-19 pandemic, with 38% of all residents infected and 5% dying. Yet, little was done to prepare these facilities for the second pandemic wave, and subsequent outbreak response strategies largely duplicated what had been done in the spring of 2020, regardless of the unique needs of the care home environment.

Methods A cross-sectional, mixed-methods study using retrospective, quantitative data from residents of 14 nursing homes between November 2020 and mid-January 2021. Four facilities were purposively selected as qualitative study sites for additional in-person, in-depth interviews in January and February 2021.

Results The average attack rate in the 14 participating nursing facilities was 39% among staff and 61% among residents. One-fifth (20) of infected residents ultimately died from COVID-19 and its complications. Failure-to-Thrive-Syndrome (FTTS) was diagnosed in 23% of COVID-positive residents. Those at highest risk of death were men (HR=1.78; IC95: 1.18 – 2.70; p=0.006) with FTTS (HR=4.04; IC95: 1.93 – 8.48; p<0.001) in facilities with delayed implementation of universal FFP2 masking policies (HR=1.05; IC95: 1.02 – 1.07; p<0.001). The lowest mortality was found in residents of facilities with a partial (HR=0.30; IC95: 0.18 – 0.51; p<0.001) or full-time physician on staff (HR=0.20; IC95: 0.08 – 0.53; p=0.001). Significant themes emerging from qualitative analysis centered on (i) the structural, chronic neglect of nursing homes, (ii) the negative effects of the top-down, bureaucratic nature of COVID-19 crisis response, and (iii) the counterproductive effects of lockdowns on both residents and staff.

Conclusion Despite high resident mortality during the first pandemic wave, French nursing homes were ill-prepared for the second, with risk factors (especially staffing, lack of medical support, isolation/quarantine policy etc) that affected case fatality and residents’ and caregivers’ overall well-being and mental health.

What is already known?

  • Though much was learned about COVID-19 in nursing homes during the first pandemic wave (Spring 2020), descriptions of the second wave in these facilities is nearly absent from the scientific literature.

  • Prior COVID-19 research in nursing homes has rarely been qualitative and has almost never interviewed care home residents themselves.

  • First-wave research indicated that much stronger outbreak and infection prevention was urgently needed to bolster nursing facilities’ preparedness. Higher staff-to-resident ratios, less staff turnover, more masks, better organization, more medical support, and more epidemiological tools were found to reduce COVID-19’s impact.

What are the new findings?

  • Our results document a lack of preparedness for the second wave, with attack rates among staff (39% overall) and residents (61% overall) similar to levels seen during the first wave peak.

  • Despite authorities’ claims to have reinforced these structures’ readiness, and despite much research into the needs in these environments, preventive measures (like strict lockdowns) remained largely unchanged and had a direct impact on residents, with 23% of COVID-positives also diagnosed with Failure-to-Thrive Syndrome.

  • Qualitative results detailed how ill-suited and inflexible some preventive measures were for residents and staff alike. Participants described precarious and understaffed living and working conditions as substantial and long-standing difficulties that became critical risks during the COVID-19 outbreak, and compromised the response.

What do the new findings imply?

  • These results suggest that knowledge gained during the first pandemic wave was not consistently applied to care home policy or practice in France, and that these nursing homes were not always safe environments that considered residents’ mental health and well-being alongside infection prevention.

  • Despite the high mortality of the first pandemic wave, French nursing homes were ill-prepared for the second. As a 5th wave descends on France (albeit with much higher COVID-19 vaccination rates), applying the lessons from previous periods (especially with regard to staffing, isolation of the elderly, medical supplies, standard of care procedures) must be prioritized.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was entirely funded by Medecins Sans Frontieres-France

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical Review Board of Medecins Sans Frontieres - France Commission Nationale de l'Informatique et des Libertes (CNIL) of France

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • morgana.dujmovic{at}gmail.com

  • thomas.roederer{at}epicentre.msf.org

  • severine.frison{at}gmail.com

  • emmanuel.grellety{at}epicentre.msf.org

  • carla.melki{at}paris.msf.org

  • thomas.lauvin{at}paris.msf.org

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 in French Nursing Homes during the Second Pandemic Wave: A Mixed-Methods Cross-Sectional Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 in French Nursing Homes during the Second Pandemic Wave: A Mixed-Methods Cross-Sectional Study
Morgane Dujmovic, Thomas Roederer, Séverine Frison, Carla Melki, Thomas Lauvin, Emmanuel Grellety
medRxiv 2021.12.12.21267681; doi: https://doi.org/10.1101/2021.12.12.21267681
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 in French Nursing Homes during the Second Pandemic Wave: A Mixed-Methods Cross-Sectional Study
Morgane Dujmovic, Thomas Roederer, Séverine Frison, Carla Melki, Thomas Lauvin, Emmanuel Grellety
medRxiv 2021.12.12.21267681; doi: https://doi.org/10.1101/2021.12.12.21267681

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1244)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (532)
  • Epidemiology (10027)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2462)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1645)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (250)
  • HIV/AIDS (535)
  • Infectious Diseases (except HIV/AIDS) (11871)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2289)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1248)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (733)
  • Pharmacology and Therapeutics (314)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4840)
  • Radiology and Imaging (838)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (286)
  • Sexual and Reproductive Health (240)
  • Sports Medicine (227)
  • Surgery (268)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)